Corient Private Wealth’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$963K Sell
5,146
-2,801
-35% -$515K ﹤0.01% 1835
2026
Q1
$1.45M Sell
7,947
-43,214
-84% -$9.1M ﹤0.01% 1440
2025
Q4
$2.11M Buy
51,161
+47,352
+1,243% +$9.57M ﹤0.01% 1508
2025
Q3
$773K Sell
3,809
-149
-4% -$26.4K ﹤0.01% 1547
2025
Q2
$697K Buy
3,958
+1,264
+47% +$190K ﹤0.01% 1530
2025
Q1
$362K Buy
2,694
+76
+3% +$10K ﹤0.01% 1758
2024
Q4
$330K Sell
2,618
-885
-25% -$132K ﹤0.01% 1843
2024
Q3
$582K Buy
3,503
+154
+5% +$23.3K ﹤0.01% 1657
2024
Q2
$446K Buy
+3,349
New +$403K ﹤0.01% 1709

Other funds holding THC

Corient Private Wealth's THC Position: Q2 2026 in Review

Corient Private Wealth reduced its Tenet Healthcare (THC) stake by 35% in Q2 2026, selling an estimated $515K and leaving 5,146 shares worth $963K. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

Corient Private Wealth first reported a position in THC in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.11M in Q4 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Corient Private Wealth held 5,146 shares of Tenet Healthcare worth $963K as of Q2 2026.
  • Corient Private Wealth sold 2,801 Tenet Healthcare shares in Q2 2026, an estimated $515K.
  • Tenet Healthcare made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1835 holding.
  • Corient Private Wealth first reported a position in Tenet Healthcare in Q2 2024 and has held it in 9 quarters since.
  • Corient Private Wealth's Tenet Healthcare position peaked at $2.11M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.